NYSE:BMY实时 60.021.121.90%2025-03-28 16:00:02 今开:59.40 昨收:58.90 今日区间:58.23-60.11 52周区间:39.35-61.08 成交量:1078.58万 成交额:64230.36万 市值:1217.81亿 市盈率:0.00 贝塔系数: 每股收益:-4.4263 盘后59.92-0.10-0.16%成交量209.54万2025-03-28 16:59...
Insider Buying: Christopher Boerner Acquires Shares of Bristol-Myers Squibb Co (BMY) GuruFocus News•7:17am Feb 20, 2025 Bristol-Myers Squibb (BMY) Announces Executive Vice President's Retirement GuruFocus News•9:32pm Feb 17, 2025
百时美施贵宝(NYSE:BMY)表示,将向SystImmune支付8亿美元的预付款,以及至多5亿美元的短期或有付款,以开发和商业化后者的一种癌症疗法。 SystImmune是中国制药企业四川生物金制药的美国企业公司,与Bristol Myers (BMY)达成独家许可和合作协议,在美国共同开发和共同商业化其EGFRxHER3双特异性抗体-药物偶联物bll - b01...
百时美施贵宝(BMY) 56.30 -0.54 ( -0.95%) 收盘, 2024-12-19 17:03:56 (美东时间) 数据延迟15分钟 +加自选 概览 图表 分时 日K 周K 月K 分钟 昨收:56.84 振幅:1.90% 成交量:1118.50万 今开:56.85 换手率:0.55% 成交额:6.30亿 最高:57.19 ...
( nyse: bmy ) is a major international pharmaceutical company that recently acquired celgene in one of the largest pharmaceutical mergers in history. following the merger, bristol-myers squibb now has multiple blockbuster therapeutics, with the majority of the company’s revenue coming from their ...
Shares of Bristol-Myers Squibb (BMY) are down today despite the drugmaker providing positive results for its schizophrenia therapy, COBENFY. The drug proved that it can provide long-lasting improvements for people with schizophrenia, with data from two m
NYSE:BMYRSS訂閱 媒體博客 訪問美通社知識庫,關注媒體和公關行業的最新動態,掌握最有價值的資訊。 我們將以更豐富的內容,更專業的形式為您提供更多元化的資訊服務。 精選視頻 數據顯示視頻、圖片等元素讓新聞稿點擊量提升77% 2021-05-07 18:57 DarwinHealth 宣佈與 Bristol Myers Squibb 合作開展一項新型的癌症...
Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid long-term pick despite short-term risks.
作者: $百时美施贵宝(BMY)$Bristol-Myers Squibb (NYSE:BMY) announces positive results from a pivotal open-label Phase 1 clinical trial, TRANSCEND-NHL-001, evaluating CAR T therapy lisocabtagene maraleucel (liso-cel) (JCAR017) in patients with relapsed/refractory large B-cell lymphomas, a ...
曼彻斯特资本管理公司(Manchester Capital Management LLC)在第四季度减少了对百时美施贵宝(Bristol-Myers Squibb,NYSE:BMY)39.3% 的持股,目前持有 13,700 股,价值 77.5 万美元。其他对冲基金也调整了他们的持仓,Contravisory Investment Management 购买了价值 48.8 万美元的新股份。百时...查看全文 相关企业信息 公...